{"nctId":"NCT01176981","briefTitle":"Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma","startDateStruct":{"date":"2010-10"},"conditions":["Osteosarcoma"],"count":6,"armGroups":[{"label":"HDMTX","type":"EXPERIMENTAL","interventionNames":["Drug: High Dose Methotrexate"]}],"interventions":[{"name":"High Dose Methotrexate","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* â‰¥ 6 years of age;\n* Localized or metastatic osteosarcoma;\n* Adequate renal function (GFR \\> 70 ml/1.73m2) prior to each cycle;\n* No grade III/IV renal toxicity, mucositis or vomiting with most recent prior inpatient MTX cycle;\n* Parent and/or patient must be able to provide written consent, and complete Patient Flow Sheets in English.\n\nExclusion Criteria:\n\n* Patients, in the opinion of the primary healthcare team, may not be able to comply with the safety monitoring requirements of the study, or in whom compliance is likely to be suboptimal.\n* Pregnant females\n* Breastfeeding females","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Years","maximumAge":"18 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Number of Outpatient High Dose Methotrexate Courses Which Result in an Inpatient Hospital Admission.","description":"Patients will be evaluated prior to and daily during each outpatient HDMTX course, and if one or more of a list of hospitalization criteria are met, the patient will be admitted to hospital to complete that course.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":[]}}}